A pharma miscellany.
April 1, 2013
By:
Ben Comer
Do Big Pharma dollars make physicians lousy caregivers?
|
|
March 1, 2013
Do terminally ill patients have a right to try unapproved, investigational drugs? Ben Comer reports.
|
February 1, 2013
By:
Ben Comer
After years of asking questions, the National Highway Traffic Safety Administration (NHTSA)is moving closer to a protocol "for assessing the driving-impairment risks of drugs". Ben Comer reports.
|
January 1, 2013
By:
Clark Herman
Thankfully, the civil war is not a public relations issue for Big Pharma, but the long-term business implications for the Middle East region are cagey.
|
|
December 1, 2012
By:
Ben Comer
Ben Comer profiles 10 innovative technologies designated as new and revolutionary tools for the treatment of disease and disability.
|
November 1, 2012
Prix Galien celebrates a new round of next generation drug technologies.
|
October 1, 2012
By:
Ben Comer
A comparative effectiveness study on the two presidential candidates.
|
September 1, 2012
By:
Ben Comer
Specialized knowledge about disease and treatment is no longer the exclusive province of practicing physicians. Patient voices are increasing in volume, along with their roles in treatment decisions.
|
August 1, 2012
By:
Julian Upton
As a drug company promoting a drug free Olympiad, GSK wins our gold hands down for finally putting the industry's best face forward on the last frontier of advertising—the TV sets of Europe.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
